Highlights the distinction between cellular/molecular hypertrophy and organ-level hypertrophy in left ventricular remodeling.
U nder acute or chronic stresses, the adult heart undergoes a remodeling process that involves cardiomyocyte hypertrophy accompanied by apoptosis, necrosis, and fibrosis that lead to impaired cardiac contractility. The role of endogenous regeneration in this process is currently under investigation. Sustained deleterious stimuli will lead to a decompensated form of hypertrophy often culminating in heart failure. When dealing with hypertrophy, it appears important to distinguish between the term being used on the cellular and molecular level (enlargement of individual cardiomyocytes and re-expression of fetal/embryonic genes) and the organ level (increased heart weight, left ventricular wall thickness, and functional diastolic and systolic impairment). In our view, these processes are certainly linked but not identical. Hypertrophy on the organ levels summarizes several independent cellular and molecular processes (see below), where cardiomyocyte growth is not necessarily the most important.
No takes yet. Share an insight, caveat, or question.
Zelarayán et al. (2010) conducted a review in Left ventricular remodeling and hypertrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: